Visiongain has published a new report entitled Global Genome Editing Technologies Market, (COVID-19 Impact Analysis):- Market Segment by Type (CRISPR, TALEN, ZFN, Antisense, Others), Market Segment by Application (Cell Line Engineering, Genetic Engineering, Diagnostic applications, Drug discovery & development, Others), Market Segment by End-user (Biotechnology companies, Pharmaceutical companies, Academic & Government Research Institutes, Others) plus COVID-19 Impact Analysis and Recovery Pattern Analysis (“V”-shaped, “W”-shaped, “U”-shaped, “L”-shaped), Profiles of Leading Companies, Region and Country.
The Global Genome Editing Technologies market is estimated to be valued at US$ 4,225.48 million in 2022. The market is projected to reach a market value of US$ 18,570.41 million by 2032. We predict strong revenue growth through to 2032
How has COVID-19 had a positive impact on the Genome Editing Technologies Market?
The COVID-19 pandemic has prompted large pharmaceutical and biotechnology firms, as well as genomic market participants, to engage in vaccine research and development. The rising need for vaccines and potential antiviral candidates has propelled genome editing/engineering technologies to the forefront. CRISPR technology was successfully used to provide rapid diagnostic tests for COVID-19,…